These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31732257)

  • 1. Discovery of covalent prolyl oligopeptidase boronic ester inhibitors.
    Plescia J; Dufresne C; Janmamode N; Wahba AS; Mittermaier AK; Moitessier N
    Eur J Med Chem; 2020 Jan; 185():111783. PubMed ID: 31732257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
    Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase.
    Szałaj N; Lu L; Benediktsdottir A; Zamaratski E; Cao S; Olanders G; Hedgecock C; Karlén A; Erdélyi M; Hughes D; Mowbray SL; Brandt P
    Eur J Med Chem; 2018 Sep; 157():1346-1360. PubMed ID: 30196059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
    Plescia J; De Cesco S; Patrascu MB; Kurian J; Di Trani J; Dufresne C; Wahba AS; Janmamode N; Mittermaier AK; Moitessier N
    J Med Chem; 2019 Sep; 62(17):7874-7884. PubMed ID: 31393718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain.
    Akçay G; Belmonte MA; Aquila B; Chuaqui C; Hird AW; Lamb ML; Rawlins PB; Su N; Tentarelli S; Grimster NP; Su Q
    Nat Chem Biol; 2016 Nov; 12(11):931-936. PubMed ID: 27595327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.
    Guardiola S; Prades R; Mendieta L; Brouwer AJ; Streefkerk J; Nevola L; Tarragó T; Liskamp RMJ; Giralt E
    Cell Chem Biol; 2018 Aug; 25(8):1031-1037.e4. PubMed ID: 29779956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
    Milo LJ; Lai JH; Wu W; Liu Y; Maw H; Li Y; Jin Z; Shu Y; Poplawski SE; Wu Y; Sanford DG; Sudmeier JL; Bachovchin WW
    J Med Chem; 2011 Jul; 54(13):4365-77. PubMed ID: 21634429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic-covalent macromolecular stars with boronic ester linkages.
    Bapat AP; Roy D; Ray JG; Savin DA; Sumerlin BS
    J Am Chem Soc; 2011 Dec; 133(49):19832-8. PubMed ID: 22103352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.
    Lawandi J; Toumieux S; Seyer V; Campbell P; Thielges S; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2009 Nov; 52(21):6672-84. PubMed ID: 19888757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.
    De Cesco S; Deslandes S; Therrien E; Levan D; Cueto M; Schmidt R; Cantin LD; Mittermaier A; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2012 Jul; 55(14):6306-15. PubMed ID: 22765237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope.
    Al-Omari MK; Elaarag M; Al-Zoubi RM; Al-Qudimat AR; Zarour AA; Al-Hurani EA; Fares ZE; Alkharraz LM; Shkoor M; Bani-Yaseen AD; Aboumarzouk OM; Yassin A; Al-Ansari AA
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2220084. PubMed ID: 37318308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders.
    Männisto PT; Venäläinen J; Jalkanen A; García-Horsman JA
    Drug News Perspect; 2007 Jun; 20(5):293-305. PubMed ID: 17878957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal peptidic boronic acids selectively inhibit human ClpXP.
    Knott K; Fishovitz J; Thorpe SB; Lee I; Santos WL
    Org Biomol Chem; 2010 Aug; 8(15):3451-6. PubMed ID: 20523950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the reversible covalent bonding of boronic acids: recognition, sensing, and assembly.
    Bull SD; Davidson MG; van den Elsen JM; Fossey JS; Jenkins AT; Jiang YB; Kubo Y; Marken F; Sakurai K; Zhao J; James TD
    Acc Chem Res; 2013 Feb; 46(2):312-26. PubMed ID: 23148559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzimidazole derivatives as effective inhibitors of prolyl oligopeptidase: synthesis,
    Shakoor A; Alam A; Jan F; Khan M; Ali M; Ullah S; Khan A; AlAsmari AF; Alasmari F; Al-Ghafri A; Al-Harrasi A
    Future Med Chem; 2024 Jan; 16(1):43-58. PubMed ID: 38054466
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies.
    Abdel-Azeem AZ; Abdel-Hafez AA; El-Karamany GS; Farag HH
    Bioorg Med Chem; 2009 May; 17(10):3665-70. PubMed ID: 19398345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro.
    Kumar R; Bavi R; Jo MG; Arulalapperumal V; Baek A; Rampogu S; Kim MO; Lee KW
    Sci Rep; 2017 Sep; 7(1):10827. PubMed ID: 28883518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.